A hundred heart failure deaths: lessons learnt from the Dr Foster heart failure hospital mortality alert

Patrick Tran1, Michelle McDonald2, Lleika Kunaselan2

  • 1Department of Cardiology, University Hospitals Coventry & Warwickshire, Coventry, United Kingdom.

Open Heart
|June 7, 2019
PubMed

Insights

Hospital standardized mortality ratios (HSMR) may not accurately reflect heart failure (HF) mortality. A review found significant gaps in care processes, including ward admission and palliative care referrals, despite lower local HF mortality rates.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement
  • Medical Auditing

Background:

  • In-hospital heart failure (HF) mortality remains high nationally, with significant interhospital variations.
  • A tertiary cardiac center received a high Hospital Standardised Mortality Ratio (HSMR) alert for HF deaths, conflicting with local data.
  • This discrepancy prompted an investigation into care processes and HSMR validity in HF.

Purpose of the Study:

  • To review systemic and individual care processes for hospitalized HF patients.
  • To examine the validity and limitations of HSMR for assessing HF mortality.

Main Methods:

  • Retrospective analysis of 100 HF deaths (2010-2016) identified by Dr Foster.
  • Case record review focusing on ward admission, resuscitation status, palliative care, diagnosis coding, and cause of death.

Main Results:

  • Only 28% of acute HF patients were admitted to cardiology wards, despite better outcomes.
  • Despite 64% being considered palliative, only 4.6% received palliative care referrals.
  • HF was incorrectly coded as a primary diagnosis in 34% of cases, and three cases were misdiagnosed.

Conclusions:

  • Significant deviations in care processes were identified for HF patients.
  • HSMR has limitations in accurately reflecting HF mortality due to coding and diagnostic inaccuracies.
  • While flawed, HSMR serves as a critical 'smoke alarm' for potential issues in HF care.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
798
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
737
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
830
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
232